Member Info for 1pencil

Assume new holder with just under 3%

https://www.londonstockexchange.com/news-article/PHC/holding-s-in-company/16146936

Good spot davey, momentum seems to be with us, relatively small free float is on our side also.

HK shorts still trending down

Forum has lost its usefulness, my entire filter list bar one is made up of posters on this thread.

"alongside our partner takeda, we are pleased to take this key step towards bringing fru*****inib to patients in japan," said dr. michael shi, head of r&d and chief medical officer of hutchmed. "supported by a strong clinical data set, and its success in china, we believe that fru*****inib is an important option for these patients and are optimistic about the impact it will have if approved in japan. there is now real regulatory momentum behind fru*****inib, and we are excited to see this drug take to the global stage."

https://www.lse.co.uk/rns/hcm/nda-submission-for-fru*****inib-in-japan-2twsm9x5g82e7j8.html

Did anyone catch the H2 guidance question during Q & A session?

JT seemed comfortable meeting Cavendish's H2 guidance of $10m being needed, one of the Jeff's also commented the second half is off to as good start.

If they can hit $15.9m for f/y that would be an incredible turnaround, we are also half way through which may reflect their positive outlook.

MOSHY and TEIKKO it is then, memorable names, I do struggle with numbers for product identification.

There's a relatively large after the bell trade, could be indicative of a worked order throughout the day.

When we look at the price on the screen its only good for the NMS, thereafter its by negotiation.

The US system of regulatory filings is similar to our TR1's but cover smaller amounts of disclosure, the only drawback is they are delayed but we still have TR1's when those thresholds are crossed.

This is an aggregate graph of those holdings:

https://images.fintel.io/gb-sfor-so.png

You can also drill down into each filing buy clicking the square icon, one or two sellers but the majority have been adding consistently.

https://fintel.io/so/gb/sfor

The recent TR1 notifications can be added in as not showing just yet due to delay mentioned above.

Patient Capital Management, LLC

https://www.lse.co.uk/rns/SFOR/holdings-in-company-2iiwkq3vjtbvatk.html

The Capital Group Companies, Inc.

https://www.lse.co.uk/rns/SFOR/holdings-in-company-i6ae110wzdtn836.html

Target says it will close nine stores in major cities

https://www.cnbc.com/2023/09/26/target-says-it-will-close-nine-stores-citing-violence-and-theft-.html

Shares of Great Portland Estates were down almost 4% around midday London time Wednesday, while British Land Company fell 2%.

https://www.cnbc.com/2023/09/27/rental-recession-london-office-vacancies-hit-30-year-high.html

OAC, lost me a bit on that one, this is the paragraph which sets it aside, that's my understanding;

"Under Note 2 on Rule 2.8 of the Code, Apollo, on behalf of its managed funds, and any person acting in concert with Apollo, reserves the right to set aside the restrictions in Rule 2.8 of the Code and announce an offer or possible offer for THG, or make or participate in an offer or possible offer for THG, and/or take any other action otherwise precluded under Rule 2.8 of the Code within six months of the date of this announcement in the following circumstances:"

Apollo have covered all bases it seems, not up to speed on topic so may have missed something or out of context.

Six month performance of NASDAQ awful, HCM not doing too bad given this - can it bust through glass ceiling at $17 ?

Market makers are obligated to buy at the best possible price for their client, this may mean pushing down the offer to encourage sellers - either that or there is a very large seller out there, its unlikely as we have seen no opposing sell TR1

10% sale of shares would cross all thresholds whether US based or not.

The trades I have put through have always been at a slight premium despite most being inside NMS.

That's not entirely correct OAC, Apollo had Rule 2.8 set aside when they issued their statement - six month wait does not apply, can come back anytime.

Several US institutions are active on S4, here's one example;

Filing date is 26th Sept, trade threshold July adding 3,267,502 shares to bring holding up to 17,884,773.

https://fintel.io/so/gb/sfor/third-avenue-trust

Comprehensive presentation with some very good answers, tbh I had none left to ask by the end - payment expected from long standing customer next month.

Both Jeff's seemed upbeat about H2, JH confirmed off to a good start.

bots, agree, your points were echoed during presentation.

Just checked US databases for 13F and NPORT Filings, nothing showing for either company so assume these are new positions.

I long suspected the drought issue was going to be a problem being too severe, webinar might add some clarification on this - it would be helpful to know if the distributor mentioned has also paid up.

This latest TR1 notification will certainly add spice to the share register, its going to make things very tight indeed.

The statement given during fund raise stated H1 trading as being strong, not sure I would count 1% as being strong.

Those in the fund raising can't be too happy.

Three tracker type funds adding recently, its small beanz but collectively it adds up, all three are at highs.

2023-09-25 NP FTIHX - Fidelity Total International Index Fund

2023-09-25 NP FSISX - Fidelity SAI International Small Cap Index Fund

2023-09-25 NP SFILX - Schwab Fundamental International Small Company Index Fund Institutional Shares

From PZC results published today

"Total St.Tropez revenue grew strongly, driven by significant share gains in the US following a launch of the Luxe Serum innovation in February, supported by our brand ambassador Ashley Graham and which created a wider halo effect for the brand in the second half of the year. The US also continued to benefit from the distribution gains made during FY22. Trading in the UK was, however, more challenging."

https://www.lse.co.uk/rns/PZC/pz-cussons-preliminary-results-a2ubu0ragmzgcpc.html

To be clear, that's not Matt saying it, this is the FCA themselves!